PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Enhertu improves progression-free survival in breast cancer trial

Positive topline results from a Phase III trial for Daiichi Sankyo and AstraZeneca’s breast cancer drug Enhertu have shown that the HER2-directed antibody drug conju...
Continue Reading →
News

SMC approves Bavencio for bladder cancer

Merck and Pfizer’s Bavencio (avelumab) has been approved by the Scottish Medicines Consortium (SMC) for use via NHS Scotland as a first-line maintenance treatment fo...
Continue Reading →
News

UK approval for Epidyolex to treat seizures from tuberous sclerosis

Jazz Pharmaceuticals subsidiary GW Pharmaceuticals has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for its cannabidiol E...
Continue Reading →
News

Santen and Sydnexis partner on childhood myopia treatment SYD-101

Santen and Sydnexis have announced an exclusive agreement to license SYD-101, an investigational treatment for progressive childhood myopia, in Europe, Middle East a...
Continue Reading →
News

CPhI partners with SGS for Company Verification Service

The ‘CPhI Verified’ certificate will provide pharma companies with an internationally accredited pre-qualification service CPhI announces the launch of CPhI Verif...
Continue Reading →
News

Syneos Health and Aetion partner to offer real-world evidence solutions

Syneos Health and Aetion have announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance drug development and improve pa...
Continue Reading →
News

BioNTech to develop a mRNA-based malaria vaccine

BioNTech has announced that the launch of a new project aimed a developing a ‘highly effective’ mRNA-based malaria vaccine candidate. The German biotech company h...
Continue Reading →
News

Four-drug combo therapy shows benefit for newly-diagnosed myeloma patients

Four-drug combination therapy has shown significant benefit for patients with newly diagnosed myeloma, according to a new analysis led by researchers from The Instit...
Continue Reading →
News

Researchers find extending the time between Pfizer doses boosts antibodies

UK researchers have found that extending the time between the first and second doses of the Pfizer/BioNTech COVID-19 vaccine boosted antibodies against all variants ...
Continue Reading →
News

EU backs approval of Moderna’s COVID-19 vaccine in 12-17 year-olds

Moderna’s COVID-19 vaccine has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for use i...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026